| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
36,112 |
16,750 |
$1.59M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,194 |
19,634 |
$1.45M |
| T2023 |
Targeted case management; per month |
2,154 |
2,131 |
$1.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,517 |
1,260 |
$73K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
582 |
539 |
$57K |
| 99205 |
Prolong outpt/office vis |
343 |
325 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,117 |
688 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
819 |
644 |
$19K |
| 80305 |
|
1,071 |
616 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
387 |
366 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
76 |
48 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
57 |
54 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
152 |
78 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
144 |
123 |
$2K |
| 99354 |
|
48 |
28 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
122 |
86 |
$1K |
| 81003 |
|
437 |
343 |
$157.79 |
| 99408 |
|
68 |
63 |
$125.88 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
23 |
15 |
$113.71 |
| 99406 |
|
12 |
12 |
$45.36 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
74 |
68 |
$0.00 |